Search research articles
Contact Us
Filters
Showing results (391-400 of 652) with videos related to
Page
of 66
Sort By:
Med (New York, N.Y.)
|
October 5, 2024
Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitis
Virginia Solitano, Remo Panaccione, Bruce E Sands, et al.
Inflammatory Bowel Diseases
|
March 4, 2025
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program
Bruce E Sands, Marla C Dubinsky, Paulo G Kotze, et al.
Journal of Personalized Medicine
|
September 28, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Crohn'S & Colitis
|
June 11, 2016
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Joana Torres, Flavio Caprioli, Konstantinos H Katsanos, et al.
Neuropharmacology
|
December 18, 2007
Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis
F Matrisciano, M Zusso, I Panaccione, et al.
Gut
|
February 15, 2007
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
W J Sandborn, S B Hanauer, P Rutgeerts, et al.
The American Journal of Gastroenterology
|
December 20, 2017
Corrigendum: Surgical Rates for Crohn's Disease Are Decreasing: A Population-Based Time Trend Analysis and Validation Study
Christopher Ma, Gordon W Moran, Eric I Benchimol, et al.
Mycotoxin Research
|
August 18, 2018
Biological activity of Claviceps gigantea in juvenile New Zealand rabbits
Alma Rosa Solano-Báez, Juan Manuel Cuca-García, Adriana Delgado-Alvarado, et al.
Oncogene
|
October 3, 2012
TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior
S V Ivanov, A Panaccione, B Brown, et al.
The American Journal of Gastroenterology
|
January 29, 2025
Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program
Andres J Yarur, Millie D Long, Joana Torres, et al.
Page
of 66
Search research articles
Search
Showing results (391-400 of 652) with videos related to
Sort By:
Page
of 66
Med (New York, N.Y.)
|
October 5, 2024
Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitis
Virginia Solitano, Remo Panaccione, Bruce E Sands, et al.
Inflammatory Bowel Diseases
|
March 4, 2025
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program
Bruce E Sands, Marla C Dubinsky, Paulo G Kotze, et al.
Journal of Personalized Medicine
|
September 28, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Crohn'S & Colitis
|
June 11, 2016
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Joana Torres, Flavio Caprioli, Konstantinos H Katsanos, et al.
Neuropharmacology
|
December 18, 2007
Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis
F Matrisciano, M Zusso, I Panaccione, et al.
Gut
|
February 15, 2007
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
W J Sandborn, S B Hanauer, P Rutgeerts, et al.
The American Journal of Gastroenterology
|
December 20, 2017
Corrigendum: Surgical Rates for Crohn's Disease Are Decreasing: A Population-Based Time Trend Analysis and Validation Study
Christopher Ma, Gordon W Moran, Eric I Benchimol, et al.
Mycotoxin Research
|
August 18, 2018
Biological activity of Claviceps gigantea in juvenile New Zealand rabbits
Alma Rosa Solano-Báez, Juan Manuel Cuca-García, Adriana Delgado-Alvarado, et al.
Oncogene
|
October 3, 2012
TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior
S V Ivanov, A Panaccione, B Brown, et al.
The American Journal of Gastroenterology
|
January 29, 2025
Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program
Andres J Yarur, Millie D Long, Joana Torres, et al.
Page
of 66